Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 27, 2023

SELL
$0.0 - $137.11 $0 - $8,912
-65 Reduced 1.27%
5,071 $0
Q1 2023

May 02, 2023

BUY
$120.16 - $144.38 $5,046 - $6,063
42 Added 0.82%
5,136 $684,000
Q4 2022

Feb 01, 2023

SELL
$119.0 - $147.98 $13,685 - $17,017
-115 Reduced 2.21%
5,094 $714,000
Q2 2022

Jul 28, 2022

SELL
$134.91 - $172.49 $4,047 - $5,174
-30 Reduced 0.57%
5,209 $741,000
Q1 2022

Apr 27, 2022

BUY
$162.31 - $192.2 $7,953 - $9,417
49 Added 0.94%
5,239 $914,000
Q4 2021

Jan 26, 2022

BUY
$166.66 - $201.06 $1,333 - $1,608
8 Added 0.15%
5,190 $1.04 Million
Q1 2021

Apr 23, 2021

SELL
$120.35 - $160.53 $178,238 - $237,744
-1,481 Reduced 22.23%
5,182 $665,000
Q4 2020

Jan 26, 2021

SELL
$122.05 - $147.91 $3.31 Million - $4.01 Million
-27,126 Reduced 80.28%
6,663 $956,000
Q3 2020

Oct 28, 2020

BUY
$97.09 - $125.51 $2.64 Million - $3.41 Million
27,140 Added 408.18%
33,789 $4.24 Million
Q1 2020

Apr 30, 2020

SELL
$66.71 - $101.73 $12,875 - $19,633
-193 Reduced 2.82%
6,649 $501,000
Q4 2019

Jan 28, 2020

SELL
$79.1 - $97.45 $45,482 - $56,033
-575 Reduced 7.75%
6,842 $664,000
Q3 2019

Oct 28, 2019

BUY
$79.44 - $98.79 $1,986 - $2,469
25 Added 0.34%
7,417 $632,000
Q1 2019

Apr 23, 2019

SELL
$72.79 - $97.5 $12,738 - $17,062
-175 Reduced 2.31%
7,392 $712,000
Q3 2018

Oct 29, 2018

SELL
$72.59 - $97.27 $97,415 - $130,536
-1,342 Reduced 15.06%
7,567 $736,000
Q2 2018

Jul 24, 2018

SELL
$72.1 - $79.39 $11,536 - $12,702
-160 Reduced 1.76%
8,909 $652,000
Q1 2018

Apr 27, 2018

SELL
$72.06 - $82.75 $7,206 - $8,275
-100 Reduced 1.09%
9,069 $687,000
Q4 2017

Feb 02, 2018

BUY
$69.36 - $73.84 $12,554 - $13,365
181 Added 2.01%
9,169 $743,000
Q3 2017

Nov 06, 2017

BUY
$62.95 - $69.48 $565,794 - $624,486
8,988
8,988 $620,000

Others Institutions Holding PKI

About PERKINELMER INC


  • Ticker PKI
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 126,224,000
  • Market Cap $15.3B
  • Description
  • PerkinElmer, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. It operates through two segments, Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment offers a suite of solutions, including reagents, informatics, and detectio...
More about PKI
Track This Portfolio

Track Moody Lynn & Lieberson, LLC Portfolio

Follow Moody Lynn & Lieberson, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Moody Lynn & Lieberson, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Moody Lynn & Lieberson, LLC with notifications on news.